AAV vectors: The Rubik's cube of human gene therapy
A Pupo, A Fernández, SH Low, A François… - Molecular Therapy, 2022 - cell.com
Defective genes account for∼ 80% of the total of more than 7,000 diseases known to date.
Gene therapy brings the promise of a one-time treatment option that will fix the errors in …
Gene therapy brings the promise of a one-time treatment option that will fix the errors in …
Prevalence, incidence and carrier frequency of 5q–linked spinal muscular atrophy–a literature review
IEC Verhaart, A Robertson, IJ Wilson… - Orphanet journal of rare …, 2017 - Springer
Spinal muscular atrophy linked to chromosome 5q (SMA) is a recessive, progressive,
neuromuscular disorder caused by bi-allelic mutations in the SMN1 gene, resulting in motor …
neuromuscular disorder caused by bi-allelic mutations in the SMN1 gene, resulting in motor …
Advances in treatment of spinal muscular atrophy–new phenotypes, new challenges, new implications for care
DC Schorling, A Pechmann… - Journal of …, 2020 - content.iospress.com
Abstract Spinal Muscular Atrophy (SMA) is caused by autosomal recessive mutations in
SMN1 and results in the loss of motor neurons and progressive muscle weakness. The …
SMN1 and results in the loss of motor neurons and progressive muscle weakness. The …
Global, regional, and national burden of motor neuron diseases 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
Background Understanding how prevalence, incidence, and mortality of motor neuron
diseases change over time and by location is crucial for understanding the causes of these …
diseases change over time and by location is crucial for understanding the causes of these …
Spinal muscular atrophy
Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disease
characterized by degeneration of alpha motor neurons in the spinal cord, resulting in …
characterized by degeneration of alpha motor neurons in the spinal cord, resulting in …
Treatment algorithm for infants diagnosed with spinal muscular atrophy through newborn screening
J Glascock, J Sampson… - Journal of …, 2018 - content.iospress.com
Background: Spinal muscular atrophy (SMA) is an autosomal recessive disease
characterized by the degeneration of alpha motor neurons in the spinal cord, leading to …
characterized by the degeneration of alpha motor neurons in the spinal cord, leading to …
Spinal muscular atrophy
MR Lunn, CH Wang - The Lancet, 2008 - thelancet.com
Spinal muscular atrophy is an autosomal recessive neurodegenerative disease
characterised by degeneration of spinal cord motor neurons, atrophy of skeletal muscles …
characterised by degeneration of spinal cord motor neurons, atrophy of skeletal muscles …
Spinal muscular atrophies
BT Darras, JA Markowitz, UR Monani… - … disorders of infancy …, 2015 - Elsevier
Spinal muscular atrophies (SMAs) are hereditary degenerative disorders of lower motor
neurons associated with progressive muscle weakness and atrophy. Proximal 5q SMA is …
neurons associated with progressive muscle weakness and atrophy. Proximal 5q SMA is …
Newborn and carrier screening for spinal muscular atrophy
TW Prior, PJ Snyder, BD Rink, DK Pearl… - American journal of …, 2010 - Wiley Online Library
Spinal muscular atrophy (SMA) is a common autosomal recessive neuromuscular disorder
caused by mutations in the survival motor neuron (SMN1) gene, affecting approximately 1 in …
caused by mutations in the survival motor neuron (SMN1) gene, affecting approximately 1 in …